iifl-logo

Trimurthi Ltd Share Price

26.61
(0.00%)
May 5, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open26.61
  • Day's High26.61
  • 52 Wk High26.61
  • Prev. Close26.61
  • Day's Low26.61
  • 52 Wk Low 17.19
  • Turnover (lac)0
  • P/E332.63
  • Face Value10
  • Book Value15.62
  • EPS0.08
  • Mkt. Cap (Cr.)66.39
  • Div. Yield0
View All Historical Data
No Records Found

Trimurthi Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

26.61

Prev. Close

26.61

Turnover(Lac.)

0

Day's High

26.61

Day's Low

26.61

52 Week's High

26.61

52 Week's Low

17.19

Book Value

15.62

Face Value

10

Mkt Cap (₹ Cr.)

66.39

P/E

332.63

EPS

0.08

Divi. Yield

0

Trimurthi Ltd Corporate Action

2 Sep 2024

12:00 AM

AGM

Announcement Date: 02 Sep, 2024

arrow

12 Apr 2025

12:00 AM

EGM

arrow

16 Sep 2024

12:00 AM

BookCloser

arrow

9 Apr 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Novelix Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Novelix Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

09 May, 2025|02:41 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 66.56%

Foreign: 0.00%

Indian: 66.56%

Non-Promoter- 33.43%

Institutions: 0.00%

Non-Institutions: 33.43%

Custodian: 0.00%

Share Price

Trimurthi Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

8.1

8.1

8.1

8.1

Preference Capital

0

0

0

0

Reserves

-0.75

-0.9

-0.86

0.7

Net Worth

7.35

7.2

7.24

8.8

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2017Mar-2016Mar-2015Mar-2014

Revenue

3.5

0.92

1.45

5.74

yoy growth (%)

277.33

-36.13

-74.63

-3.58

Raw materials

-2.84

0

-0.32

-4.24

As % of sales

81.2

0

22.17

73.84

Employee costs

-0.21

-0.23

-0.06

-0.33

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2017Mar-2016Mar-2015Mar-2014

Profit before tax

0.2

0.13

0.08

0.6

Depreciation

-0.12

-0.33

-0.39

-0.28

Tax paid

-0.05

-0.03

-0.06

-0.19

Working capital

1.37

-1.5

-0.84

0.27

Other operating items

View Cash Flow
Y/e 31 MarMar-2017Mar-2016Mar-2015Mar-2014

Growth matrix (%)

Revenue growth

277.33

-36.13

-74.63

-3.58

Op profit growth

-53.77

-18.59

-45.17

8.52

EBIT growth

50.64

47.78

-85.1

11.11

Net profit growth

53.57

427.68

-95.52

10.19

View Ratios
Particulars (Rupees in Crores.)Mar-2022Mar-2021Mar-2020Mar-2019Mar-2018

Gross Sales

8.61

9.24

10.24

10.46

10.5

Excise Duty

0

0

0

0

0

Net Sales

8.61

9.24

10.24

10.46

10.5

Other Operating Income

0

0

0

0

0

Other Income

0.64

0.34

0.6

0.38

0.21

Trimurthi Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,766.2

134.524,23,770.541,181.050.765,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,958.35

76.31,58,175.475940.52,297513.62

Cipla Ltd

CIPLA

1,486.75

25.81,20,075.941,438.150.874,134.87360.72

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,183

59.051,07,722.354850.882,330222.38

Mankind Pharma Ltd

MANKIND

2,434.1

51.931,00,425.74416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Trimurthi Ltd

Management

Register Office

Registrar Office

Independent Director

Monam Kapoor

Independent Director

Janardhan Das Kabra

Whole-time Director

Venkateshwarlu Pulluru

Company Sec. & Compli. Officer

Nishita Kalantri

Additional Director

Jivamohan Divakar Valluri

Additional Director

Lakshman Samala

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company. Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016.Initially, the company was engaged in finance and investments in securities. They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company. Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.In November 2009, the Company received NS-EN ISO 9001:2008 / ISO 9001:2008 for marketing and distribution of pharmaceutical products from Kvalitet Veritas Quality Assurance. They had been appointed as Authorized Distributors on all India level for Livewell Food products and ABLE, Pharma, in the Salon District of Himachal Pradesh.During the year 2010-11, the Company started their first Pharmacy Retail Outlet in Himayath Nagar, Hyderabad. Also, they started their second retail outlet at Inderbagh, Sultan Bazar, Hyderabad. The Company with its full capacity commenced the business operations in food industry business through its wholly owned subsidiary in 2018.The Co
Read More

Company FAQs

What is the Novelix Pharmaceuticals Ltd share price today?

The Novelix Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹26.61 today.

What is the Market Cap of Novelix Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Novelix Pharmaceuticals Ltd is ₹66.39 Cr. as of 05 May ‘25

What is the PE and PB ratio of Novelix Pharmaceuticals Ltd?

The PE and PB ratios of Novelix Pharmaceuticals Ltd is 332.63 and 1.70 as of 05 May ‘25

What is the 52 Week High and Low of Novelix Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Novelix Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Novelix Pharmaceuticals Ltd is ₹17.19 and ₹26.61 as of 05 May ‘25

What is the CAGR of Novelix Pharmaceuticals Ltd?

Novelix Pharmaceuticals Ltd's CAGR for 5 Years at 67.31%, 3 Years at 41.46%, 1 Year at 54.80%, 6 Month at 15.70%, 3 Month at 4.97% and 1 Month at 0.00%.

What is the shareholding pattern of Novelix Pharmaceuticals Ltd?

The shareholding pattern of Novelix Pharmaceuticals Ltd is as follows:
Promoters - 66.56 %
Institutions - 0.00 %
Public - 33.44 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.